 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
steroid hormone mediated signaling pathway
|
2 terms
|
 |
|
Biochemical function
|
DNA binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
95:5998-6003
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.
|
|
D.M.Tanenbaum,
Y.Wang,
S.P.Williams,
P.B.Sigler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The 2.8-A crystal structure of the complex formed by estradiol and the human
estrogen receptor-alpha ligand binding domain (hERalphaLBD) is described and
compared with the recently reported structure of the progesterone complex of the
human progesterone receptor ligand binding domain, as well as with similar
structures of steroid/nuclear receptor LBDs solved elsewhere. The hormone-bound
hERalphaLBD forms a distinctly different and probably more physiologically
important dimer interface than its progesterone counterpart. A comparison of the
specificity determinants of hormone binding reveals a common structural theme of
mutually supported van der Waals and hydrogen-bonded interactions involving
highly conserved residues. The previously suggested mechanism by which the
estrogen receptor distinguishes estradiol's unique 3-hydroxy group from the
3-keto function of most other steroids is now described in atomic detail.
Mapping of mutagenesis results points to a coactivator-binding surface that
includes the region around the "signature sequence" as well as helix
12, where the ligand-dependent conformation of the activation function 2 core is
similar in all previously solved steroid/nuclear receptor LBDs. A peculiar
crystal packing event displaces helix 12 in the hERalphaLBD reported here,
suggesting a higher degree of dynamic variability than expected for this
critical substructure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Arrangement of hER LBDs in the
crystal structure. (A) The tetramer formed by the intermolecular
disulfide bonds between Cys-530 of neighboring hER LBD
molecules and dimerization around the local dyad. (Inset) A
schematization of the arrangement. Positions of the disulfides
are marked with a yellow disc with red "S." Red symbols in the
center of the tetramer and schematic show the crystallographic
dyad, and the red arrow in the inset indicates the
noncrystallographic symmetry dyad. (B) Comparison of the dimers
of holo-hER LBD,
apo-hRXR LBD, and
holo-hPRLBD viewed down the local dyad (17, 18). The dimer
interfaces of holo-hER LBD and
apo-hRXR LBD are
similar, with helices 7-10 as the major contributors. The
holo-hPRLBD dimer interface is substantially different, composed
predominantly of helices 11 and 12, as well as the extreme
C-terminal tail. Drawn with RIBBONS (29).
|
 |
Figure 3.
Fig. 3. Specificity determinants of the hormone-binding
site specifies 3-hydroxy vs. 3-keto steroids. (A) The
hydrogen-bonding network as seen in the hER LBD and
hPRLBD (18). The discriminating relationship of Glu/Gln to the
3-hydroxy/keto of the steroid is supported by a network of
water-mediated hydrogen bonds involving the side chain of a
conserved Arg and backbone carbonyl of a conserved Phe that, in
turn, are fixed by hydrophobic contacts with the steroid ring.
Note that the PR has no obvious hydrogen bonding discrimination
at the 20-keto position of progesterone comparable to the
hydrogen-bonding interaction seen between the 17-hydroxyl of
estradiol and His-524. (B) Space-filling representation of
estradiol in the ligand-binding pocket of hER LBD and
progesterone in the ligand-binding pocket of hPRLBD (18). For
the proteins, carbon atoms are gray, oxygen atoms red, sulfur
atoms yellow and nitrogen atoms blue. For the hormones, carbon
atoms are cyan, oxygen atoms magenta. Drawn with MIDAS (36). (C)
Schematic of estradiol in the hER LBD
ligand-binding pocket in the structure shown here; hormone (red)
rings are lettered, and carbon atoms are numbered. Residues
hydrogen bonded directly to the hormone are blue. Dashed lines
indicate hydrophobic van der Waals contacts with the hormone.
Residues conserved among the steroid receptors are green, and
variable residues are black. Residues contributed by helix 12
(1) are not shown.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.De-Eknamkul,
K.Umehara,
O.Monthakantirat,
R.Toth,
V.Frecer,
L.Knapic,
P.Braiuca,
H.Noguchi,
and
S.Miertus
(2011).
QSAR study of natural estrogen-like isoflavonoids and diphenolics from Thai medicinal plants.
|
| |
J Mol Graph Model, 29,
784-794.
|
 |
|
|
|
|
 |
Y.Huang,
X.Li,
and
M.Muyan
(2011).
Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.
|
| |
Endocrine, 39,
48-61.
|
 |
|
|
|
|
 |
J.Kelder,
R.Azevedo,
Y.Pang,
J.de Vlieg,
J.Dong,
and
P.Thomas
(2010).
Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists.
|
| |
Steroids, 75,
314-322.
|
 |
|
|
|
|
 |
N.C.Nicolaides,
Z.Galata,
T.Kino,
G.P.Chrousos,
and
E.Charmandari
(2010).
The human glucocorticoid receptor: molecular basis of biologic function.
|
| |
Steroids, 75,
1.
|
 |
|
|
|
|
 |
P.Huang,
V.Chandra,
and
F.Rastinejad
(2010).
Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.
|
| |
Annu Rev Physiol, 72,
247-272.
|
 |
|
|
|
|
 |
R.Goyanka,
S.Das,
H.H.Samuels,
and
T.Cardozo
(2010).
Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.
|
| |
Protein Eng Des Sel, 23,
809-815.
|
 |
|
|
|
|
 |
C.Byrne,
S.D.Divekar,
G.B.Storchan,
D.A.Parodi,
and
M.B.Martin
(2009).
Cadmium--a metallohormone?
|
| |
Toxicol Appl Pharmacol, 238,
266-271.
|
 |
|
|
|
|
 |
C.M.Klinge
(2009).
Estrogen Regulation of MicroRNA Expression.
|
| |
Curr Genomics, 10,
169-183.
|
 |
|
|
|
|
 |
H.Ogawa,
T.Shinoda,
F.Cornelius,
and
C.Toyoshima
(2009).
Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain.
|
| |
Proc Natl Acad Sci U S A, 106,
13742-13747.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Pick,
S.Etter,
O.Baud,
R.Schmauder,
L.Bordoli,
T.Schwede,
and
H.Vogel
(2009).
Dual activities of odorants on olfactory and nuclear hormone receptors.
|
| |
J Biol Chem, 284,
30547-30555.
|
 |
|
|
|
|
 |
M.E.Baker,
D.J.Chang,
and
C.Chandsawangbhuwana
(2009).
3D model of lamprey estrogen receptor with estradiol and 15alpha-hydroxy-estradiol.
|
| |
PLoS One, 4,
e6038.
|
 |
|
|
|
|
 |
M.J.Tetel
(2009).
Nuclear receptor coactivators: essential players for steroid hormone action in the brain and in behaviour.
|
| |
J Neuroendocrinol, 21,
229-237.
|
 |
|
|
|
|
 |
M.J.Tetel,
A.P.Auger,
and
T.D.Charlier
(2009).
Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.
|
| |
Front Neuroendocrinol, 30,
328-342.
|
 |
|
|
|
|
 |
M.K.Dennis,
R.Burai,
C.Ramesh,
W.K.Petrie,
S.N.Alcon,
T.K.Nayak,
C.G.Bologa,
A.Leitao,
E.Brailoiu,
E.Deliu,
N.J.Dun,
L.A.Sklar,
H.J.Hathaway,
J.B.Arterburn,
T.I.Oprea,
and
E.R.Prossnitz
(2009).
In vivo effects of a GPR30 antagonist.
|
| |
Nat Chem Biol, 5,
421-427.
|
 |
|
|
|
|
 |
P.Li,
A.K.Bandyopadhyaya,
D.F.Covey,
J.H.Steinbach,
and
G.Akk
(2009).
Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation.
|
| |
Br J Pharmacol, 158,
1322-1329.
|
 |
|
|
|
|
 |
R.Kumar,
and
G.Litwack
(2009).
Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain.
|
| |
Steroids, 74,
877-883.
|
 |
|
|
|
|
 |
S.Ellmann,
H.Sticht,
F.Thiel,
M.W.Beckmann,
R.Strick,
and
P.L.Strissel
(2009).
Estrogen and progesterone receptors: from molecular structures to clinical targets.
|
| |
Cell Mol Life Sci, 66,
2405-2426.
|
 |
|
|
|
|
 |
T.Kino,
Y.A.Su,
and
G.P.Chrousos
(2009).
Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology.
|
| |
Cell Mol Life Sci, 66,
3435-3448.
|
 |
|
|
|
|
 |
D.Pugazhendhi,
K.A.Watson,
S.Mills,
N.Botting,
G.S.Pope,
and
P.D.Darbre
(2008).
Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells.
|
| |
J Endocrinol, 197,
503-515.
|
 |
|
|
|
|
 |
J.T.Bridgham,
J.E.Brown,
A.Rodríguez-Marí,
J.M.Catchen,
and
J.W.Thornton
(2008).
Evolution of a new function by degenerative mutation in cephalochordate steroid receptors.
|
| |
PLoS Genet, 4,
e1000191.
|
 |
|
|
|
|
 |
M.Paris,
K.Pettersson,
M.Schubert,
S.Bertrand,
I.Pongratz,
H.Escriva,
and
V.Laudet
(2008).
An amphioxus orthologue of the estrogen receptor that does not bind estradiol: insights into estrogen receptor evolution.
|
| |
BMC Evol Biol, 8,
219.
|
 |
|
|
|
|
 |
M.Schubert,
F.Brunet,
M.Paris,
S.Bertrand,
G.Benoit,
and
V.Laudet
(2008).
Nuclear hormone receptor signaling in amphioxus.
|
| |
Dev Genes Evol, 218,
651-665.
|
 |
|
|
|
|
 |
R.Narayanan,
M.L.Mohler,
C.E.Bohl,
D.D.Miller,
and
J.T.Dalton
(2008).
Selective androgen receptor modulators in preclinical and clinical development.
|
| |
Nucl Recept Signal, 6,
e010.
|
 |
|
|
|
|
 |
T.Harada,
K.Yamagishi,
T.Nakano,
K.Kitaura,
and
H.Tokiwa
(2008).
Ab initio fragment molecular orbital study of ligand binding to human progesterone receptor ligand-binding domain.
|
| |
Naunyn Schmiedebergs Arch Pharmacol, 377,
607-615.
|
 |
|
|
|
|
 |
V.Cura,
M.Gangloff,
S.Eiler,
D.Moras,
and
M.Ruff
(2008).
Cleaved thioredoxin fusion protein enables the crystallization of poorly soluble ERalpha in complex with synthetic ligands.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
54-57.
|
 |
|
|
|
|
 |
A.M.Hassell,
G.An,
R.K.Bledsoe,
J.M.Bynum,
H.L.Carter,
S.J.Deng,
R.T.Gampe,
T.E.Grisard,
K.P.Madauss,
R.T.Nolte,
W.J.Rocque,
L.Wang,
K.L.Weaver,
S.P.Williams,
G.B.Wisely,
R.Xu,
and
L.M.Shewchuk
(2007).
Crystallization of protein-ligand complexes.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
72-79.
|
 |
|
|
|
|
 |
C.M.Eakin,
M.J.Maccoss,
G.L.Finney,
and
R.E.Klevit
(2007).
Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
|
| |
Proc Natl Acad Sci U S A, 104,
5794-5799.
|
 |
|
|
|
|
 |
D.L.Bain,
A.F.Heneghan,
K.D.Connaghan-Jones,
and
M.T.Miura
(2007).
Nuclear receptor structure: implications for function.
|
| |
Annu Rev Physiol, 69,
201-220.
|
 |
|
|
|
|
 |
E.Estébanez-Perpiñá,
L.A.Arnold,
A.A.Arnold,
P.Nguyen,
E.D.Rodrigues,
E.Mar,
R.Bateman,
P.Pallai,
K.M.Shokat,
J.D.Baxter,
R.K.Guy,
P.Webb,
and
R.J.Fletterick
(2007).
A surface on the androgen receptor that allosterically regulates coactivator binding.
|
| |
Proc Natl Acad Sci U S A, 104,
16074-16079.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Iwamoto,
T.Mizutani,
and
K.Kano
(2007).
Thermodynamics of hydrophobic interactions: entropic recognition of a hydrophobic moiety by poly(ethylene oxide)-zinc porphyrin conjugates.
|
| |
Chem Asian J, 2,
1267-1275.
|
 |
|
|
|
|
 |
K.A.Green,
and
J.S.Carroll
(2007).
Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.
|
| |
Nat Rev Cancer, 7,
713-722.
|
 |
|
|
|
|
 |
M.R.Calgaro,
M.d.e. .O.Neto,
A.C.Figueira,
M.A.Santos,
R.V.Portugal,
C.A.Guzzi,
D.M.Saidemberg,
L.Bleicher,
J.Vernal,
P.Fernandez,
H.Terenzi,
M.S.Palma,
and
I.Polikarpov
(2007).
Orphan nuclear receptor NGFI-B forms dimers with nonclassical interface.
|
| |
Protein Sci, 16,
1762-1772.
|
 |
|
|
|
|
 |
Y.E.Timsit,
and
M.Negishi
(2007).
CAR and PXR: the xenobiotic-sensing receptors.
|
| |
Steroids, 72,
231-246.
|
 |
|
|
|
|
 |
L.Toschi,
J.Hilbig,
T.Wintermantel,
A.Engelhaupt,
A.Walter,
K.H.Fritzemeier,
and
A.Hillisch
(2006).
Protein-structure-based prediction of animal model suitability for pharmacodynamic studies of subtype-selective estrogens.
|
| |
ChemMedChem, 1,
1237-1248.
|
 |
|
|
|
|
 |
P.Ascenzi,
A.Bocedi,
and
M.Marino
(2006).
Structure-function relationship of estrogen receptor alpha and beta: impact on human health.
|
| |
Mol Aspects Med, 27,
299-402.
|
 |
|
|
|
|
 |
P.D.Darbre
(2006).
Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast.
|
| |
J Appl Toxicol, 26,
191-197.
|
 |
|
|
|
|
 |
Y.Shang
(2006).
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
|
| |
Nat Rev Cancer, 6,
360-368.
|
 |
|
|
|
|
 |
Y.Wang,
N.Y.Chirgadze,
S.L.Briggs,
S.Khan,
E.V.Jensen,
and
T.P.Burris
(2006).
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta.
|
| |
Proc Natl Acad Sci U S A, 103,
9908-9911.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.E.Bohl,
D.D.Miller,
J.Chen,
C.E.Bell,
and
J.T.Dalton
(2005).
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.
|
| |
J Biol Chem, 280,
37747-37754.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Fukuzawa,
K.Kitaura,
M.Uebayasi,
K.Nakata,
T.Kaminuma,
and
T.Nakano
(2005).
Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
|
| |
J Comput Chem, 26,
1.
|
 |
|
|
|
|
 |
S.Yoon,
A.Smellie,
D.Hartsough,
and
A.Filikov
(2005).
Computational identification of proteins for selectivity assays.
|
| |
Proteins, 59,
434-443.
|
 |
|
|
|
|
 |
A.E.Carpenter,
A.Ashouri,
and
A.S.Belmont
(2004).
Automated microscopy identifies estrogen receptor subdomains with large-scale chromatin structure unfolding activity.
|
| |
Cytometry A, 58,
157-166.
|
 |
|
|
|
|
 |
M.L.Privalsky
(2004).
The role of corepressors in transcriptional regulation by nuclear hormone receptors.
|
| |
Annu Rev Physiol, 66,
315-360.
|
 |
|
|
|
|
 |
S.Top,
A.Vessières,
P.Pigeon,
M.N.Rager,
M.Huché,
E.Salomon,
C.Cabestaing,
J.Vaissermann,
and
G.Jaouen
(2004).
Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.
|
| |
Chembiochem, 5,
1104-1113.
|
 |
|
|
|
|
 |
B.C.Kallenberger,
J.D.Love,
V.K.Chatterjee,
and
J.W.Schwabe
(2003).
A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.
|
| |
Nat Struct Biol, 10,
136-140.
|
 |
|
|
|
|
 |
D.Anderson,
T.E.Schmid,
A.Baumgartner,
E.Cemeli-Carratala,
M.H.Brinkworth,
and
J.M.Wood
(2003).
Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the Comet assay).
|
| |
Mutat Res, 544,
173-178.
|
 |
|
|
|
|
 |
E.Diamanti-Kandarakis,
G.P.Sykiotis,
and
A.G.Papavassiliou
(2003).
Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
|
| |
Cancer, 97,
12-20.
|
 |
|
|
|
|
 |
H.Tamura,
H.Yoshikawa,
K.W.Gaido,
S.M.Ross,
R.K.DeLisle,
W.J.Welsh,
and
A.M.Richard
(2003).
Interaction of organophosphate pesticides and related compounds with the androgen receptor.
|
| |
Environ Health Perspect, 111,
545-552.
|
 |
|
|
|
|
 |
N.Foy,
E.Stéphan,
A.Vessières,
E.Salomon,
J.M.Heldt,
M.Huché,
and
G.Jaouen
(2003).
Synthesis, receptor binding, molecular modeling, and proliferative assays of a series of 17alpha-arylestradiols.
|
| |
Chembiochem, 4,
494-503.
|
 |
|
|
|
|
 |
T.Mordasini,
A.Curioni,
R.Bursi,
and
W.Andreoni
(2003).
The binding mode of progesterone to its receptor deduced from molecular dynamics simulations.
|
| |
Chembiochem, 4,
155-161.
|
 |
|
|
|
|
 |
X.Wang,
X.Qian,
H.C.Guo,
and
J.Hu
(2003).
Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.
|
| |
J Virol, 77,
4471-4480.
|
 |
|
|
|
|
 |
A.Koide,
S.Abbatiello,
L.Rothgery,
and
S.Koide
(2002).
Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.
|
| |
Proc Natl Acad Sci U S A, 99,
1253-1258.
|
 |
|
|
|
|
 |
A.Ohno,
M.Shimizu,
and
S.Yamada
(2002).
Fluorinated vitamin D analogs to probe the conformation of vitamin D in its receptor complex: 19F-NMR studies and biological activity.
|
| |
Chem Pharm Bull (Tokyo), 50,
475-483.
|
 |
|
|
|
|
 |
L.L.Hart,
and
J.R.Davie
(2002).
The estrogen receptor: more than the average transcription factor.
|
| |
Biochem Cell Biol, 80,
335-341.
|
 |
|
|
|
|
 |
M.Hentschke,
U.Süsens,
and
U.Borgmeyer
(2002).
Domains of ERRgamma that mediate homodimerization and interaction with factors stimulating DNA binding.
|
| |
Eur J Biochem, 269,
4086-4097.
|
 |
|
|
|
|
 |
R.L.Rich,
L.R.Hoth,
K.F.Geoghegan,
T.A.Brown,
P.K.LeMotte,
S.P.Simons,
P.Hensley,
and
D.G.Myszka
(2002).
Kinetic analysis of estrogen receptor/ligand interactions.
|
| |
Proc Natl Acad Sci U S A, 99,
8562-8567.
|
 |
|
|
|
|
 |
S.H.McLaughlin,
and
S.E.Jackson
(2002).
Folding and stability of the ligand-binding domain of the glucocorticoid receptor.
|
| |
Protein Sci, 11,
1926-1936.
|
 |
|
|
|
|
 |
X.Gu
(2002).
Helix 12 in the human estrogen receptor (hER) is essential for the hER function by overcoming nucleosome repression in yeast.
|
| |
J Cell Biochem, 86,
224-238.
|
 |
|
|
|
|
 |
Y.B.Shi,
J.W.Ritchie,
and
P.M.Taylor
(2002).
Complex regulation of thyroid hormone action: multiple opportunities for pharmacological intervention.
|
| |
Pharmacol Ther, 94,
235-251.
|
 |
|
|
|
|
 |
A.C.Pike,
A.M.Brzozowski,
J.Walton,
R.E.Hubbard,
A.G.Thorsell,
Y.L.Li,
J.A.Gustafsson,
and
M.Carlquist
(2001).
Structural insights into the mode of action of a pure antiestrogen.
|
| |
Structure, 9,
145-153.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.M.Klinge
(2001).
Estrogen receptor interaction with estrogen response elements.
|
| |
Nucleic Acids Res, 29,
2905-2919.
|
 |
|
|
|
|
 |
D.Ghosh,
and
P.Vihko
(2001).
Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1.
|
| |
Chem Biol Interact, 130,
637-650.
|
 |
|
|
|
|
 |
I.Zelko,
T.Sueyoshi,
T.Kawamoto,
R.Moore,
and
M.Negishi
(2001).
The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.
|
| |
Mol Cell Biol, 21,
2838-2846.
|
 |
|
|
|
|
 |
J.G.Savory,
G.G.Préfontaine,
C.Lamprecht,
M.Liao,
R.F.Walther,
Y.A.Lefebvre,
and
R.J.Haché
(2001).
Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.
|
| |
Mol Cell Biol, 21,
781-793.
|
 |
|
|
|
|
 |
K.Pettersson,
and
J.A.Gustafsson
(2001).
Role of estrogen receptor beta in estrogen action.
|
| |
Annu Rev Physiol, 63,
165-192.
|
 |
|
|
|
|
 |
M.Schumacher,
R.Guennoun,
G.Mercier,
F.Désarnaud,
P.Lacor,
J.Bénavides,
B.Ferzaz,
F.Robert,
and
E.E.Baulieu
(2001).
Progesterone synthesis and myelin formation in peripheral nerves.
|
| |
Brain Res Brain Res Rev, 37,
343-359.
|
 |
|
|
|
|
 |
N.Greenfield,
V.Vijayanathan,
T.J.Thomas,
M.A.Gallo,
and
T.Thomas
(2001).
Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy.
|
| |
Biochemistry, 40,
6646-6652.
|
 |
|
|
|
|
 |
S.Kobayashi,
T.Sugaya,
N.Sakata,
M.Uebayasi,
K.Sameshima,
and
A.Tanaka
(2001).
Prediction of endocrine disruptors based on a new structure-activity relationship for sex and environmental hormones using chemical hardness concept.
|
| |
Chem Pharm Bull (Tokyo), 49,
680-688.
|
 |
|
|
|
|
 |
T.Tsuji,
M.Onimaru,
and
H.Yanagawa
(2001).
Random multi-recombinant PCR for the construction of combinatorial protein libraries.
|
| |
Nucleic Acids Res, 29,
E97.
|
 |
|
|
|
|
 |
Y.C.Kao,
K.R.Korzekwa,
C.A.Laughton,
and
S.Chen
(2001).
Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
|
| |
Eur J Biochem, 268,
243-251.
|
 |
|
|
|
|
 |
Y.Endo,
T.Iijima,
Y.Yamakoshi,
H.Fukasawa,
C.Miyaura,
M.Inada,
A.Kubo,
and
A.Itai
(2001).
Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
|
| |
Chem Biol, 8,
341-355.
|
 |
|
|
|
|
 |
Y.Shi,
and
J.T.Koh
(2001).
Selective regulation of gene expression by an orthogonal estrogen receptor-ligand pair created by polar-group exchange.
|
| |
Chem Biol, 8,
501-510.
|
 |
|
|
|
|
 |
A.Stoica,
E.Pentecost,
and
M.B.Martin
(2000).
Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
|
| |
J Cell Biochem, 79,
282-292.
|
 |
|
|
|
|
 |
C.Hellal-Levy,
J.Fagart,
A.Souque,
and
M.E.Rafestin-Oblin
(2000).
Mechanistic aspects of mineralocorticoid receptor activation.
|
| |
Kidney Int, 57,
1250-1255.
|
 |
|
|
|
|
 |
D.B.Defranco
(2000).
Role of molecular chaperones in subnuclear trafficking of glucocorticoid receptors.
|
| |
Kidney Int, 57,
1241-1249.
|
 |
|
|
|
|
 |
D.F.Smith
(2000).
Chaperones in progesterone receptor complexes.
|
| |
Semin Cell Dev Biol, 11,
45-52.
|
 |
|
|
|
|
 |
E.L.Yong,
J.Lim,
W.Qi,
V.Ong,
and
A.Mifsud
(2000).
Molecular basis of androgen receptor diseases.
|
| |
Ann Med, 32,
15-22.
|
 |
|
|
|
|
 |
I.Grishkovskaya,
G.V.Avvakumov,
G.Sklenar,
D.Dales,
G.L.Hammond,
and
Y.A.Muller
(2000).
Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain.
|
| |
EMBO J, 19,
504-512.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Wurtz,
B.Guillot,
J.Fagart,
D.Moras,
K.Tietjen,
and
M.Schindler
(2000).
A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: a homology modeling and docking approach.
|
| |
Protein Sci, 9,
1073-1084.
|
 |
|
|
|
|
 |
J.W.Thornton,
and
R.DeSalle
(2000).
Gene family evolution and homology: genomics meets phylogenetics.
|
| |
Annu Rev Genomics Hum Genet, 1,
41-73.
|
 |
|
|
|
|
 |
K.Yamamoto,
H.Masuno,
M.Choi,
K.Nakashima,
T.Taga,
H.Ooizumi,
K.Umesono,
W.Sicinska,
J.VanHooke,
H.F.DeLuca,
and
S.Yamada
(2000).
Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
|
| |
Proc Natl Acad Sci U S A, 97,
1467-1472.
|
 |
|
|
|
|
 |
M.B.Hawkins,
J.W.Thornton,
D.Crews,
J.K.Skipper,
A.Dotte,
and
P.Thomas
(2000).
Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts.
|
| |
Proc Natl Acad Sci U S A, 97,
10751-10756.
|
 |
|
|
|
|
 |
M.Ruff,
M.Gangloff,
J.M.Wurtz,
and
D.Moras
(2000).
Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors.
|
| |
Breast Cancer Res, 2,
353-359.
|
 |
|
|
|
|
 |
N.Swamy,
W.Xu,
N.Paz,
J.C.Hsieh,
M.R.Haussler,
G.J.Maalouf,
S.C.Mohr,
and
R.Ray
(2000).
Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
|
| |
Biochemistry, 39,
12162-12171.
|
 |
|
|
|
|
 |
S.F.Wang,
S.Ayer,
W.A.Segraves,
D.R.Williams,
and
A.S.Raikhel
(2000).
Molecular determinants of differential ligand sensitivities of insect ecdysteroid receptors.
|
| |
Mol Cell Biol, 20,
3870-3879.
|
 |
|
|
|
|
 |
W.Bourguet,
P.Germain,
and
H.Gronemeyer
(2000).
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.
|
| |
Trends Pharmacol Sci, 21,
381-388.
|
 |
|
|
|
|
 |
A.C.Pike,
A.M.Brzozowski,
R.E.Hubbard,
T.Bonn,
A.G.Thorsell,
O.Engström,
J.Ljunggren,
J.A.Gustafsson,
and
M.Carlquist
(1999).
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
|
| |
EMBO J, 18,
4608-4618.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Mueller-Fahrnow,
and
U.Egner
(1999).
Ligand-binding domain of estrogen receptors.
|
| |
Curr Opin Biotechnol, 10,
550-556.
|
 |
|
|
|
|
 |
A.W.Norman,
D.Adams,
E.D.Collins,
W.H.Okamura,
and
R.J.Fletterick
(1999).
Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
|
| |
J Cell Biochem, 74,
323-333.
|
 |
|
|
|
|
 |
D.Kosztin,
S.Izrailev,
and
K.Schulten
(1999).
Unbinding of retinoic acid from its receptor studied by steered molecular dynamics.
|
| |
Biophys J, 76,
188-197.
|
 |
|
|
|
|
 |
D.P.McDonnell
(1999).
The Molecular Pharmacology of SERMs.
|
| |
Trends Endocrinol Metab, 10,
301-311.
|
 |
|
|
|
|
 |
F.F.Moebius,
K.E.Soellner,
B.Fiechtner,
C.W.Huck,
G.Bonn,
and
H.Glossmann
(1999).
Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization.
|
| |
Biochemistry, 38,
1119-1127.
|
 |
|
|
|
|
 |
F.J.Ghadessy,
J.Lim,
A.A.Abdullah,
V.Panet-Raymond,
C.K.Choo,
R.Lumbroso,
T.G.Tut,
B.Gottlieb,
L.Pinsky,
M.A.Trifiro,
and
E.L.Yong
(1999).
Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
|
| |
J Clin Invest, 103,
1517-1525.
|
 |
|
|
|
|
 |
H.Tanaka,
Y.Makino,
K.Okamoto,
T.Iida,
K.Yan,
and
N.Yoshikawa
(1999).
Redox regulation of the glucocorticoid receptor.
|
| |
Antioxid Redox Signal, 1,
403-423.
|
 |
|
|
|
|
 |
I.J.McEwan
(1999).
Investigation of steroid receptor function in the budding yeast Saccharomyces cerevisiae.
|
| |
FEMS Microbiol Lett, 176,
1-9.
|
 |
|
|
|
|
 |
J.Zhang,
X.Hu,
and
M.A.Lazar
(1999).
A novel role for helix 12 of retinoid X receptor in regulating repression.
|
| |
Mol Cell Biol, 19,
6448-6457.
|
 |
|
|
|
|
 |
L.A.Sheldon,
C.L.Smith,
J.E.Bodwell,
A.U.Munck,
and
G.L.Hager
(1999).
A ligand binding domain mutation in the mouse glucocorticoid receptor functionally links chromatin remodeling and transcription initiation.
|
| |
Mol Cell Biol, 19,
8146-8157.
|
 |
|
|
|
|
 |
R.V.Weatherman,
R.J.Fletterick,
and
T.S.Scanlan
(1999).
Nuclear-receptor ligands and ligand-binding domains.
|
| |
Annu Rev Biochem, 68,
559-581.
|
 |
|
|
|
|
 |
S.Aliau,
H.Mattras,
E.Richard,
and
J.L.Borgna
(1999).
Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
|
| |
Biochemistry, 38,
14752-14762.
|
 |
|
|
|
|
 |
S.H.Hong,
and
M.L.Privalsky
(1999).
Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha.
|
| |
J Biol Chem, 274,
2885-2892.
|
 |
|
|
|
|
 |
A.K.Shiau,
D.Barstad,
P.M.Loria,
L.Cheng,
P.J.Kushner,
D.A.Agard,
and
G.L.Greene
(1998).
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
|
| |
Cell, 95,
927-937.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|